NCT07420400 Non-Invasive Detection of Right-to-Left Cardiac Shunts
| NCT ID | NCT07420400 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Scripps Health |
| Condition | Patent Foramen Ovale (PFO) |
| Study Type | OBSERVATIONAL |
| Enrollment | 75 participants |
| Start Date | 2026-01-07 |
| Primary Completion | 2027-01-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 75 participants in total. It began in 2026-01-07 with a primary completion date of 2027-01-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study will test the sensitivity of a novel, battery-powered, non-invasive ultrasound device to detect a right-to-left shunt
Eligibility Criteria
Undergoing clinically indicated TEE with bubble study for the detection of a PFO
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07420400 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Patent Foramen Ovale (PFO). Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07420400 currently recruiting?
Yes, NCT07420400 is actively recruiting participants. Contact the research team at price.matthew@scrippshealth.org for enrollment information.
Where is the NCT07420400 trial being conducted?
This trial is being conducted at La Jolla, United States.
Who is sponsoring the NCT07420400 clinical trial?
NCT07420400 is sponsored by Scripps Health. The trial plans to enroll 75 participants.